Author:
Miyoshi Koho,Morita Yoshio,Ueki Akinori
Reference33 articles.
1. Bartolini L, Casamenti F, Pepeu G (1996) Aniracetam restores object recognition impaired by age, scopolamine, and nucleus basalis lesions. Pharmacol Biochem Behav 53:277–281
2. Bergamasco B, Villardita C, Coppi R (1992) Idebenone in the treatment of multi-infarct dementia. A randomised double-blind, placebo controlled muticentre trial. Arch Gerontol Geriatr 15:271–278
3. Bores GM, Huger FP, Petko W, et al (1996) Pharmacological evaluation of novel Alzheimer’s disease therapeutics. Acetylcholinestrase inhibitors related to galantamine. J Pharmacol Exp Ther 277:728–738
4. Burke WJ, Roccaforte WH, Wengel SP, et al (1993) L-Deprenyl in the treatment of mild dementia of the Alzheimer type: results of a IS-month trial. Am J Geriatr Soc 41:1219–1225
5. Burns A, Rossor M, Hecker J, et al (1999) The effects of donepezil in Alzheimer’s disease: results froma a multinational trial. Dementia Geriatr Cogn Disord 10:237–244